$1.290
-0.048 (-3.73%)收盘时
DRMA 资讯
DRMA 事件
Dermata Therapeutics Officially Launches Tome Foundational Treatment
Dermata Therapeutics announced the official commercial launch of the Tome Foundational Treatment, the first product available for purchase under the Company's Tome skincare brand. The Foundational Treatment is now available for immediate purchase at www.tomeskincare.com, either as a one-time purchase or through a monthly subscription at a discounted price.
Dermata Therapeutics Opens Preorders for Tome Foundational Treatment
Dermata Therapeutics announced that Tome Foundational Treatment, the Company's first direct-to-consumer skincare product, is now open to preorders. The Tome Foundational Treatment is expected to start shipping on August 25, 2026.
Dermata Therapeutics Announces Launch of First Skincare Product on August 25, 2026
Dermata Therapeutics announced that Tome Foundational Treatment, the Company's first direct-to-consumer skincare product, is planned to launch on August 25, 2026, with those on the waitlist getting early access to preorder. The launch of the Foundational Treatment represents a significant milestone in Dermata's strategic evolution toward becoming a consumer-focused, revenue-generating, skincare company. Tome is built around the concept of bringing professional-grade solutions to the homes of skincare enthusiasts. The brand is designed to address growing consumer demand for accessible skincare that incorporate the science and efficacy associated with professional treatments, while fitting seamlessly into weekly routines.
Dermata Therapeutics Appoints Kyra Peckaitis as VP of Marketing
Dermata Therapeutics announced the appointment of Kyra Peckaitis as Vice President, Marketing. Ms. Peckaitis is a multi-disciplinary brand marketer and will lead Dermata's new brand launch, Tome Skincare. Ms. Peckaitis will oversee the marketing strategy, brand development, and consumer engagement initiatives as Tome gets ready to bring its first commercial products to market in the middle of 2026. Prior to Dermata, Ms. Peckaitis served as Associate Director, Brand Marketing for Coterie, a direct-to-consumer baby care brand.
Dermata Therapeutics Launches Tome Skincare Brand
Dermata Therapeutics announces the branding of its latest innovation in skincare: Tome, which aims to introduce "skintech at home". The Company's Tome skincare line will bring intentionally developed skincare that delivers a high level of efficacy by addressing the root causes of skin diseases and conditions. Tome is Studied Skincare, utilizing timeless ingredients with modern innovations for today's curious skincare consumer. Dermata believes there is immense market opportunity to offer all-natural, multi-action, high-performing skincare treatments directly to consumers for a professional aesthetician feel at home .While first targeting the launch of an over the counter, once-weekly acne and resurfacing treatment in mid-2026, Dermata believes its Tome product line will become part of an essential foundation for enhancing overall skin quality and beauty.
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。